E133: Obinutuzumab for SLE (ALLEGORY)

The Evidence Based Rheumatology Podcast by Michael Putman

Mar 19, 202615:21Health

Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: Landing Page: Substack:

Related Episodes

Continue listening to more episodes from The Evidence Based Rheumatology Podcast.

E138: Dapirolizumab for SLE (PHOENYCS-GO)

Jul 24, 2026 - 22:09

A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The s...

E137: Obexelimab in IgG4-RD (INDIGO)

Jun 29, 2026 - 15:36

Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less...

E136: Secukinumab in PMR (REPLENISH)

Jun 15, 2026 - 13:39

Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I...

E135: IL17 and a GLP1?

Apr 30, 2026 - 11:03

Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzep...

E134: Brepocitinib in Dermatomyositis (VALOR)

Apr 17, 2026 - 14:58

Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be...

E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)

Mar 5, 2026 - 13:54

Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if -...

E131: A Sham-Controlled Sham of a Trial: RESET-RA

Jan 21, 2026 - 14:48

Today I cover the recent publication of the RESET-RA study, which evaluated vagal nerve stimulation to tr...

E130: Telitacicept for SLE

Dec 22, 2025 - 13:06

Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patien...